Latest filing published 21 Mar 2018 for Aralez Pharmaceuticals Inc., €13k.
Filing timeline
BuySaleInsider track record
Eric Trachtenberg: trading record in brief
All filings by Eric Trachtenberg on record concern Aralez Pharmaceuticals Inc. The record holds 8 filings, for trades running from 5 February 2016 to 19 March 2018.
Market trades split into 1 purchase (€26k) and 2 sales (€11k). The net balance comes to €15k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 4 option exercises. So far in 2018, the count stands at no purchases and 1 sale.
Most recently, on 21 March 2018, the filings show an option exercise worth €13k in Aralez Pharmaceuticals Inc. The clock since the last published purchase (18 May 2016) now reads 3,826 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Eric Trachtenberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,501 shares@ CA$1.838.9% of flowCommon SharesTSXSEDI:3157867
- 3,471 shares@ CA$1.702.5% of flowCommon SharesTSXSEDI:3157870
- 25,000 shares@ CA$1.3347.4% of flowCommon SharesTSXSEDI:3025644
- 7,720 shares@ CA$1.3314.6% of flowCommon SharesTSXSEDI:3025646
- 11,499 shares@ CA$2.2537.9% of flowCommon SharesTSXSEDI:2982163
- 25,000 shares@ CA$3.3439.0% of flowCommon SharesTSXSEDI:2855829
- 10,000 shares@ CA$3.75717.4% of flowCommon SharesTSXSEDI:2839437Canonical exit: 14 Aug 2016 (T+90)
- Common SharesTSXSEDI:2787419
8 of 8 declarations